Abstract:Abstract Multiple primary cancer (MPC) is becoming more common in the general population, accounting for approximately 20% of incidence cases in the United States. Epidemiological studies indicate a strong dependence of the subsequent primary on the characteristics of the first primary. For example, there is evidence that individuals with a first primary breast cancer is more likely to develop a second primary lung cancer. These observations highlight the need to develop a statistical model that characterizes age-to-onset of cancers beyond the first primary, while accounting for the complex relationships between the cancer occurrences. Such a modeling framework was previously lacking. We hereby propose a Bayesian semiparametric framework, where the occurrences of each cancer type follow a non-homogeneous Poisson process. The time-varying intensity of this process is conditioned on genetic and demographic covariates, such as status of genetic mutation and sex, as well as on a patient’s cancer history, such as type and timing of the first primary, thus allowing our model to capture the heterogeneity in cancer risks across individuals. Since our model requires a dataset that is enriched with MPC cases, we utilize data collected from families affected with Li-Fraumeni Syndrome (LFS), which is a genetic disorder characterized by germline mutations in the tumor-suppressor gene TP53. People with LFS are at higher risks of certain cancer types, and many cancer survivors develop additional primary malignancy. We train and cross-validate our model on a patient cohort selected according to clinical LFS criteria at MD Anderson Cancer Center from year 2000 to 2015. The cohort consists of 11,186 individuals across 429 families, out of which 2,286 were diagnosed with at least one primary cancer and 335 were tested positive for germline mutations in TP53. Upon model training, we construct cancer-specific penetrance curves for the second primary cancer, which vary considerably among patients with different covariates and cancer history, thus highlighting the utility of our model for personalized risk prediction. Our penetrance estimates display good performance when being used to make cancer-specific predictions of the second primary among cancer survivors, achieving AUCs (Areas under the Receiver Operating Characteristic curves) of 0.91, 0.76 and 0.68 respectively for sarcoma, breast cancer, and all other cancers combined. While we apply our model to an LFS dataset, the statistical framework is general, and can be tailored to analyze any time-to-event datasets with suitably selected sets of covariates. Future applications include population-based characterization of specific cancer type combinations over time to impact public health policy making. Citation Format: Nam H. Nguyen, Elissa B. Dodd-Eaton, Seung Jun Shin, Jing Ning, Wenyi Wang. Bayesian estimation of a semi-parametric recurrent event model with competing outcomes for personalized risk prediction among cancer survivors. [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 5761.

Cytochrome c Oxidase from Bakers ’ Yeast Ii

[Phytotherapeutic drug in bilharziasis?].

Evaluation of Machine Learning Algorithms for the Prognosis of Breast Cancer from the Surveillance, Epidemiology, and End Results Database

Personalized Risk Prediction for Cancer Survivors: A Bayesian Semi-parametric Recurrent Event Model with Competing Outcomes

Abstract 5761: Bayesian estimation of a semi-parametric recurrent event model with competing outcomes for personalized risk prediction among cancer survivors

Long-term survival and second malignant tumor prediction in pediatric, adolescent, and young adult cancer survivors using Random Survival Forests: a SEER analysis

Improving personalized tumor growth predictions using a Bayesian combination of mechanistic modeling and machine learning

Bayesian Modelling of Response to Therapy and Drug-Sensitivity in Acute Lymphoblastic Leukemia

Survival trend and outcome prediction for pediatric Hodgkin and non-Hodgkin lymphomas based on machine learning

Helical Computed Tomography of the Liver: Techniques, Applications and Pitfalls

Predicting lung cancer survival prognosis based on the conditional survival bayesian network

Survival prediction in acute myeloid leukemia using gene expression profiling

Survival Rate Prediction of Blood Cancer (Leukemia) Patients Using Machine Learning Algorithms

The development of a prediction model based on random survival forest for the prognosis of non- Hodgkin lymphoma: A prospective cohort study in China

Superficial punctate keratitis and corneal abrasion due to amantadine hydrochloride

Competitive Risk Model for Specific Mortality Prediction in Patients with Bladder Cancer: A Population-Based Cohort Study with Machine Learning

Machine learning-based evaluation of prognostic factors for mortality and relapse in patients with acute lymphoblastic leukemia: a comparative simulation study

Prediction model for survival of younger patients with breast cancer using the breast cancer public staging database

Survival Prediction in Non-Small Cell Lung Cancer Patients: Performance Evaluation of Machine Learning Ensemble Models (Preprint)

Parametric Models for Survival Analysis of Childhood Cancer Patients' Data

An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy